Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nao Shoshihara
Institution:
Osaka Police Hospital
Observed institution:
Osaka Police Hospital
ORCID:
0009-0008-0576-0312
Observed ORCID:
0009-0008-0576-0312
OpenAlex ID:
A5076448147
Cerebral Infarction Caused by Trousseau’s Syndrome Associated With Lung Cancer
2022
·
Shoko Ikuta
, Kanako Nishimatsu
, et al.
·
World Journal of Oncology
·
5
PDF
Sarcoid-Like Granulomatosis of the Lung Related to Durvalumab After Chemoradiation for Pulmonary Squamous Cell Carcinoma
2023
·
Seigo Minami
, Hironao Yasuoka
, et al.
·
Journal of Medical Cases
·
3
PDF
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLC
2025
·
Kensuke Kanaoka
, Kinnosuke Matsumoto
, et al.
·
JTO Clinical and Research Reports
·
2
PDF
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer
2026
·
Kinnosuke Matsumoto
, Yuji Yamamoto
, et al.
·
European Journal of Cancer
·
1
PDF
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non‐Squamous Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study
2026
·
Keijiro Yamauchi
, Kinnosuke Matsumoto
, et al.
·
Thoracic Cancer
·
1
A Case of Radiation-Associated Vertebral Compression Fracture Mimicking Solitary Bone Metastasis of Lung Cancer
2023
·
Shoko Ikuta
, Nao Shoshihara
, et al.
·
Journal of Medical Cases
·
1
PDF
Long-Term Responders to Erlotinib for Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor: Two Case Reports and a Single-Institutional Retrospective Study
2023
·
Seigo Minami
, Nao Shoshihara
·
World Journal of Oncology
·
1
PDF
Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy
2026
·
Hirotomo Machiyama
, Kinnosuke Matsumoto
, et al.
·
Respiratory Medicine
Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study
2025
·
Nao Shoshihara
, Kinnosuke Matsumoto
, et al.
·
Lung Cancer
PDF
Show more works
View as search
Works count:
9
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type